Company intelligence / Profile preview

Cambridge Investments

Fairfield, Iowa, United States

Ownership: Private
Employees: ~900
Development stage: Other

Overview

Cambridge Investment Research is a large, privately-controlled financial services firm and independent broker-dealer. While the company is not a biotechnology or pharmaceutical developer, it provides investment management, financial planning, and advisory services to a broad range of clients, including those in the healthcare and life sciences sectors. The firm is known for its independent model, supporting thousands of financial professionals across the United States. Its business focus remains on wealth management, retirement planning, and brokerage services rather than drug discovery or clinical development.

Industry: Investors

Beyond the preview

Go deeper on Cambridge Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cambridge Investments.

Explore the full profile